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The ability to monitor kinase activity dynamics in live
cells greatly aids the study of how signaling events
are spatiotemporally regulated. Here, we report on
the adaptability of bimolecular kinase activity re-
porters (bimKARs) as molecular tools to enhance
the real-time visualization of kinase activity. We
demonstrate that the bimKARdesign is truly versatile
and can be used to monitor a variety of kinases,
including JNK, ERK, and AMPK. Furthermore, bim-
KARs can have significantly enhanced dynamic
ranges over their unimolecular counterparts, allow-
ing the elucidation of previously undetectable kinase
activity dynamics. Using these newly designed
bimKARs, we investigate the regulation of AMPK by
protein kinase A (PKA) in the plasma membrane,
and demonstrate that PKA can both negatively and
positively regulate AMPK activity in the same cell.
INTRODUCTION
In live cells, signal transduction of extracellular cues requires
exquisite spatial and temporal regulation of numerousmolecules
dispersed throughout the cellular milieu to elicit specific re-
sponses. For example, protein kinases aid cellular communica-
tion by altering substrate activity, cellular localization, and/or
association with other proteins. Cells employ a variety of mech-
anisms to tightly regulate protein kinase activity in space and
time to ensure that signals are properly transduced. A multitude
of different methods have been employed over the years to study
kinase behavior and better understand how kinase signaling
functions in cells. Traditional biochemical approaches such as
western blotting, immunostaining, and in vitro kinase activity as-
says, which have greatly fostered our general understanding of
kinase signaling, only provide fixed glimpses of signal transduc-
tion, a process that is constantly in flux. Thus, various fluores-
cence-based kinase activity biosensors have been developed
to allow real-time monitoring of signaling dynamics. For
example, peptide-based biosensors incorporate organic fluoro-
phores into peptides or protein-interaction domains such that
phosphorylation yields enhanced fluorescent properties such
as emission wavelength or quantum yield (Rothman et al.,1470 Chemistry & Biology 22, 1470–1479, November 19, 2015 ª20152005; Sharma et al., 2008; Tarrant and Cole, 2009). These bio-
sensors offer a large dynamic range and are able to detect kinase
signaling in live cells; however, they can be unstable in cells and
often requiremicroinjection (Tarrant andCole, 2009). Unlike pep-
tide-based biosensors, genetically encodable fluorescence
resonance energy transfer (FRET)-based biosensors circumvent
cell-entry issues by relying on the native cellular machinery for
expression. Moreover, this method accommodates the incorpo-
ration of subcellular localization sequences and thus allows for
the investigation of kinase signaling dynamics in precise spatial
compartments (Mehta and Zhang, 2011).
FRET-based kinase activity reporters (KARs) serve as surro-
gate substrates for the kinases of interest and report their activity
dynamics via changes in FRET. KARs utilize a kinase-inducible
molecular switch consisting of a substrate sequence and a phos-
phoamino acid binding domain (PAABD) that binds to the
phosphorylated substrate, sandwiched between two spectrally
different fluorescent proteins (FPs) capable of undergoing
FRET (Depry and Zhang, 2010). A myriad of different FRET-
based activity biosensors have been created to study individual
kinases, including Akt (Gao and Zhang, 2008), Src (Wang et al.,
2005), insulin receptor (Sato and Umezawa, 2004; Sato et al.,
2002), epidermal growth factor receptor (Ting et al., 2001),
c-Jun N-terminal kinase (JNK) (Fosbrink et al., 2010), and
AMP-activated protein kinase (AMPK) (Tsou et al., 2011), among
others (Newman et al., 2011). Furthermore, the modular design
of KARs has enabled the creation of many new reporters through
the substitution of one kinase-specific substrate and/or PAABD
for another. This tactic was employed to generate KARs for pro-
tein kinase D (D kinase activity reporter) and extracellular signal-
regulated kinase (ERK kinase activity reporter, EKAR), which
were derived fromC kinase activity reporter and A kinase activity
reporter (AKAR), respectively (Harvey et al., 2008; Violin et al.,
2003). Many novel insights have been made possible using the
available FRET-based biosensors. For example, a recent study
using EKAR revealed stochastic Erk activity pulses in cultured
epithelial cells, thus illuminating the role of spontaneous Erk ac-
tivity in regulating cell proliferation (Aoki et al., 2013). Another
study using FRET-based reporters for FAK and Src revealed
the differential activation of these two kinases directed stem
cells to adopt different cell fates (Liao et al., 2013).
KARs are invaluable tools for studying kinase activity dy-
namics, but their utility may be restricted by limited dynamic
ranges, which can hinder the detection of subtle yet physiologi-
cally relevant changes in kinase activity (Herbst et al., 2011;Elsevier Ltd All rights reserved
Hodgson et al., 2010). For example, in insulin-secreting MIN6 b
cells, protein kinase A (PKA) oscillates in sync with Ca2+ and cy-
clic AMP (cAMP), contributing to precise control of spatially
localized or global PKA activity, despite the small amplitude of
activity oscillations (Ni et al., 2011). Further building upon the
modular nature of KARs in an attempt to enhance the dynamic
range of these biosensors, recent advances have led to the
development of bimolecular KARs (bimKARs). In bimKARs, a
single polypeptide encoding the PAABD attached to one FP is
expressed along with a separate polypeptide containing the ki-
nase-specific substrate attached to the second FP of the FRET
pair. The separation of the FRET pair is thought to enhance the
dynamic range, likely by decreasing the occurrence of basal
FRET between the FPs, since they are much further apart than
in a unimolecular biosensor. For example, the bimolecular A ki-
nase activity reporter, bimAKAR, specifically detects PKA activ-
ity in cells and, when targeted to the plasma membrane, exhibits
a larger dynamic range than the corresponding unimolecular
AKAR (Herbst et al., 2011). Although successful at visualizing ki-
nase signaling, only a small number of bimKARs have been
created, and it remains to be tested how generalizable this
design is. In this study, we show that bimKARs are highly versa-
tile and can be used to enhance our ability to detect and monitor
various kinase activities in living cells. We constructed bimKARs
that incorporate kinase docking domains and utilize different
PAABDs. In addition, we created bimKARs that enabled us to
delve into the regulation of AMPK activity within discrete subcel-
lular compartments, revealing that AMPK activity at the plasma
membrane experiences both positive and negative regulation
by PKA within the same cell.
RESULTS
Including a Kinase Docking Domain in the BimKAR
Design
A number of kinases require docking domains to ensure specific
phosphorylation of their target substrates, including members of
the mitogen-activated protein kinase (MAPK) family. MAPKs rely
upon kinase-specific docking domains within scaffolds and
target proteins to help mediate structural and functional organi-
zation by bringing the kinase and substrate into a multiprotein
complex (Dhanasekaran et al., 2007; Sharrocks et al., 2000),
thus enhancing the specificity and efficiency of substrate phos-
phorylation. As a subgroup of the MAPK family, the JNKs are no
exception; even in the case of identical phosphoacceptor sites,
JNK fails to phosphorylate substrates that specifically lack a
docking domain (Katz and Aronheim, 2002). As such, the incor-
poration of a docking domain was essential to the successful
generation of the JNK activity reporter (JNKAR1) (Fosbrink
et al., 2010).
To determine whether a bimKAR design is compatible with the
inclusion of a docking domain, we used unimolecular JNKAR1 as
a model to develop bimJNKAR, making certain to keep the
substrate and docking domain part of the same fragment.
BimJNKAR consists of the CFP variant Cerulean (Rizzo et al.,
2004) fused to the phosphothreonine (pThr)-binding forkhead-
associated 1 (FHA1) domain, and the yellow fluorescent protein
(YFP) variant YPet (Nguyen and Daugherty, 2005) fused to a Jun
dimerization protein 2 (JDP2) peptide linked to the JDP2 dockingChemistry & Biology 22, 1470–147domain (‘‘substrate + DD,’’ Figure 1A). Both halves of bimJNKAR
are targeted to the cytoplasm via a C-terminal nuclear export
signal (NES). In HeLa cells treated with anisomycin, an inhibitor
of protein synthesis that robustly activates JNK, yellow fluores-
cence increased at the expense of cyan fluorescence, yielding
a change in the yellow-to-cyan emission ratio of 36.6% ± 4.5%
(n = 25) (mean ± SEM, n = number of cells). The dynamic range
of bimJNKAR is significantly larger than that of unimolecular
JNKAR1-NES (20.3% ± 01.6%, n = 19, p < 0.01), most probably
due to reduced levels of basal FRET in the dissociated, unstimu-
lated state of the reporter (Figures 1C and 1D). The response to
anisomycin stimulation was abolished when the phosphorylation
site wasmutated to alanine (T/A), as well as when cells were pre-
treated with JNK inhibitor VIII (a JNK-specific inhibitor [Szcze-
pankiewicz et al., 2006]) (Figure 1B), indicating that bimJNKAR
is a selective reporter of JNK activity.
Substituting the PAABD in the BimKAR Design
To further establish the adaptability of bimKARs, we evaluated
the impact of changing the PAABD in addition to investigating
the effect of docking domains. To date, fewer than 20 specific
serine/threonine (Ser/Thr) FRET-based KARs have been gener-
ated that rely on an engineered molecular switch consisting of
a kinase-specific substrate and a PAABD. Although the majority
of these use FHA as the PAABD (Depry et al., 2011; Fosbrink
et al., 2010; Fuller et al., 2008; Gallegos et al., 2006; Gao and
Zhang, 2008; Komatsu et al., 2011; Kunkel et al., 2007; Macurek
et al., 2008; Tomida et al., 2009; Tsou et al., 2011; Wang et al.,
2005), a few notable exceptions do exist. For example, EKAR uti-
lizes the proline-directed WW domain from human Pin1 as the
PAABD (Harvey et al., 2008). Unlike FHA, theWWdomain recog-
nizes both phosphoserine (pSer)- and phosphothreonine (pThr)-
containing sequences. FHA1 contains 11 well-defined b sheets,
whereas the much smaller WW domain consists of only two b
sheets (Huang and Chang, 2011). In addition, FHA1 has a higher
affinity for phosphopeptides compared with the WW domain.
Dissociation constants (KD) for FHA1 and phosphopeptides are
frequently in the 100-nM range (Durocher et al., 2000; Liao
et al., 2000; Yongkiettrakul et al., 2004), whereas KDs for the
WW domain can range from 5 to 100 mM (Dalby et al., 2000; Ver-
decia et al., 2000; Wintjens et al., 2001). These differences in af-
finity pose a potential concern in the development of WW
domain-based bimKARs, as the weaker affinity of the WW
domain for phosphopeptides could hinder intermolecular bind-
ing to the substrate-containing fragment. To test this effect, we
therefore created bimEKAR, which consists of Cerulean fused
to a WW domain and Venus (YFP) fused to a Cdc25C peptide
and the ERK docking site (‘‘substrate + DD’’), with both halves
tagged with an NES for cytoplasmic localization (Figure 2A).
Our results suggest that the weaker binding affinity of the WW
domain for phosphopeptides does not prevent it from being
used in a bimolecular design. In Cos7 cells treated with
epidermal growth factor (EGF), which potently stimulates ERK,
bimEKAR responded with an emission ratio change of 9.3% ±
1.3% (n = 11) (Figures 2B–2D). The response to EGF stimulation
was eliminated when the phosphorylation site was mutated to
alanine (T/A), as well as when the cells were pretreated with
the MEK inhibitor U0126 (Duncia et al., 1998) (Figure 2B), indi-
cating that bimEKAR selectively responds to phosphorylation9, November 19, 2015 ª2015 Elsevier Ltd All rights reserved 1471
Figure 1. Development of a Bimolecular
JNK Activity Reporter
(A) Schematic diagram of domain structures for
unimolecular JNKAR1-NES and bimolecular
JNKAR (bimJNKAR). The JNK substrate/docking
domain (DD) sequence is shown with the target
threonine (T) residue highlighted in red andmarked
with an asterisk.
(B) Representative single-cell traces of HeLa
cells expressing JNKAR1-NES (black curve),
bimJNKAR (red curve), or a non-phosphorylatable
bimJNKAR mutant (negative control; blue curve)
treated with 5 mM anisomycin. ‘‘+ inhibitor’’ (green
curve) indicates HeLa cells expressing bimJNKAR
that were pretreated for 1 hr with 20 mM JNK in-
hibitor VIII.
(C) Summary bar graph comparing the average
maximum response for JNKAR1-NES and
bimJNKAR upon anisomycin treatment. Data
shown represent mean ± SEM. **p < 0.01 ac-
cording to unpaired Student’s t test.
(D) Representative pseudocolored images
showing the responses of JNKAR1-NES and
bimJNKAR to 5 mM anisomycin treatment in HeLa
cells. Warmer colors correspond to increasing
FRET ratios. CFP and YFP images show the
cellular distribution of probe fluorescence. The
arrowhead (inverted triangle) indicates the time at
which drug was added during the imaging experi-
ments. Scale bar represents 10 mm.by ERK. The overall dynamic range of bimEKAR is similar to that
of EKARcyto (10.7%± 1.4%, n = 7) (Figures 2B–2D); however, this
may not be completely unexpected. Given that the WW domain
does have a lower affinity for phosphosubstrates, it is possible
that any gains in dynamic range caused by a decrease in basal
FRET are being counterbalanced by this lower affinity.
Using BimKARs to Study Compartmentalized Kinase
Activity
The ability to probe enzyme activities within specific subcellular
compartments can provide crucial insights into how signaling
pathways are organized. Given their genetic encodability, fluo-
rescent biosensors can be targeted to different regions of the
cell with relative ease by incorporating various targeting
sequences (Mehta et al., 2014; Zhou et al., 2015). However, teth-
ering a biosensor to a cellular structure such as the plasmamem-
brane can restrict the dynamic range of the reporter, thereby
making it difficult to obtain a robust signal, especially when at-
tempting to detect subtle changes in kinase activity. For
example, the previously described unimolecular reporter for
AMPK activity, or AMPKAR (Tsou et al., 2011), displays a negli-
gible response to stimulation when targeted to the plasma
membrane (Figure S1). This effect is not necessarily solvable
through reporter optimization alone: we recently reported an1472 Chemistry & Biology 22, 1470–1479, November 19, 2015 ª2015 Elsevier Ltd All rights rimproved AMPKAR variant, termed
ABKAR (Sample et al., 2015), and while
this reporter displays a substantially
higher dynamic range (Figure S1), the
response from plasma membrane-teth-
ered ABKAR is still greatly diminished(Figure S1). Given the versatile nature of bimKARs, we therefore
tested whether switching to a bimolecular design would improve
the response and allow us to investigate plasma membrane
compartmentalized AMPK activity.
Cytosolic bimABKAR (Figure 3A) and plasma membrane-tar-
geted bimABKAR-Kras (Figure 3E) both use the same Ceru-
lean-FHA1-NES fragment described above. For bimABKAR,
the other half of the biomolecular switch contains an AMPK sub-
stratemotif identical to that found in AMPKAR and ABKAR (Sam-
ple et al., 2015; Tsou et al., 2011) fused to YPet, along with a
C-terminal NES. For bimABKAR-Kras, a plasma membrane tar-
geting motif was incorporated in place of the NES. In Cos7 cells
treated with the nonhydrolyzable glucose analog 2-deoxyglu-
cose (2DG), which lowers ATP levels by inhibiting glycolysis,
bimABKAR exhibits a FRET ratio increase of 30.6% ± 2.4%
(n = 19), similar to the 36.4% ± 1.5% (n = 18) change observed
using ABKAR-NES (Figures 3B–3D), while mutating the phos-
phorylation site within bimABKAR or pretreating cells with the
AMPK-specific inhibitor compound C blocked the response to
2DG (Figure 3B). By contrast, bimABKAR-Kras exhibited a
55.7% ± 4.1% (n = 9) ratio change, which represents a dramatic
improvement over the response from ABKAR-Kras (7.0% ±
1.1%, n = 15) (Figures 3F–3H). The physical separation of the
Cerulean and YPet components of bimABKAR-Kras may reduceeserved
Figure 2. Development of a Bimolecular
ERK Activity Reporter
(A) Schematic diagram of domain structures for
EKARcyto and bimEKAR. The ERK substrate/
docking domain (DD) sequence is shown with the
target threonine (T) residue highlighted in red and
marked with an asterisk.
(B) Representative single-cell traces of Cos7 cells
expressing EKARcyto (black curve), bimEKAR
(red curve), or a non-phosphorylatable bimEKAR
mutant (negative control; blue curve) treated with
100 ng/ml EGF. ‘‘+ inhibitor’’ (green curve) in-
dicates Cos7 cells expressing bimEKAR that were
pretreated for 1 hr with 10 mM U0126. Cells were
serum starved for 20 min prior to imaging.
(C) Summary bar graph comparing the average
maximum responses of EKARcyto and bimEKAR
upon EGF stimulation. Data shown represent
mean ± SEM.
(D)Representativepseudocolored images showing
the responses of EKARcyto and bimEKAR to
100 ng/ml EGF treatment in Cos7 cells. Warmer
colors correspond to increasing FRET ratios. CFP
and YFP images show the cellular distribution of
probe fluorescence. The arrowhead (inverted tri-
angle) indicates the time at which drug was added
during the imaging experiments. Scale bar repre-
sents 10 mm.the basal FRET and thus enhance the dynamic range of the
plasma membrane-targeted bimolecular reporter. The signifi-
cantly larger dynamic range of bimABKAR-Kras allows for the
visualization of previously undetectable local kinase signaling
and suggests that bimKAR conversion may be a useful strategy
for improving the dynamic ranges of subcellularly targeted re-
porters, further highlighting the general utility of bimKARs.
Bidirectional Regulation of Plasma Membrane AMPK
Activity by PKA
AMPK is an evolutionarily conserved master regulator of cellular
and whole-body energy homeostasis. Cellular processes that
deplete ATP, thus increasing AMP levels, activate AMPK, which
contributes to carbohydrate, lipid, and protein metabolism, as
well as cell polarity, growth, and insulin secretion (Kahn et al.,
2005; Steinberg and Kemp, 2009). The latter is of particular inter-
est, in part because metformin and thiazolidinediones, widely
used drug treatments for type 2 diabetes, have been shown to
function by increasing AMPK activity (Chang et al., 2009; Puljak
et al., 2008). As a master regulator of metabolic homeostasis,
AMPK activity is modulated by at least five different kinases
(Steinberg and Kemp, 2009). Prominent among these are liver ki-
nase B1 (LKB1) and calmodulin kinase kinase (CaMKK), whichChemistry & Biology 22, 1470–1479, November 19, 2015both activate AMPK by phosphorylating
Thr172 in the activation loop (Hawley
et al., 1995; 1996; 2003; Hong et al.,
2003). AMPK has also been shown to
engage in a rather complex relationship
with cAMP-dependent protein kinase
(PKA). For instance, several studies have
shown that PKA directly phosphorylates
and inhibits AMPK (Cao et al., 2014;Djouder et al., 2010; Garcia-Haro et al., 2012; Hurley et al.,
2006; Pulinilkunnil et al., 2011). In particular, PKA phosphorylates
Ser173 within the activation loop, which occludes the activation
site Thr172 (Djouder et al., 2010). However, PKA has also been
shown to stimulate AMPK activity (Kimball et al., 2004; Yin
et al., 2003). Notably, PKA is known to promote axon initiation
by stimulating LKB1 (Shelly et al., 2007), and the elevated
AMPK activity (Sample et al., 2015) and cAMP levels (Shelly
et al., 2010) observed in axons may suggest a possible route
for PKA to enhance AMPK activity.
Given these varying reports, we set out to further examine the
dynamics of AMPK regulation by PKA in living cells. In particular,
we previously demonstrated that PKA is basally active at the
plasma membrane in unstimulated cells (Depry et al., 2011);
therefore, we used bimABKAR-Kras to investigate how this basal
PKA activity regulates AMPK activity at the plasma membrane.
When Cos7 cells expressing bimABKAR-Kras were treated
with H89 to inhibit basal PKA activity, we observed only a mini-
mal change in the FRET response (1.9% ± 0.8%, n = 8) (Figures
4A and 4E), although cells expressing AKAR4-Kras exhibited a
5.4% ± 0.6% (n = 9) ratio decrease, consistent with the presence
of basal PKA activity (Figure S2). However, when these cells were
subsequently deprived of glucose to activate AMPK (seeª2015 Elsevier Ltd All rights reserved 1473
Figure 3. Development of a Biomolecular AMPK Activity Reporter
(A and E) Schematic diagrams of domain structures for (A) ABKAR-NES and bimABKAR or (E) ABKAR-Kras and bimABKAR-Kras. The AMPK substrate sequence
is shown with the target threonine (T) residue highlighted in red and marked with an asterisk.
(B and F) Representative single-cell traces of Cos7 cells expressing (B) ABKAR-NES (black curve), bimABKAR (red curve), or a non-phosphorylatable bimABKAR
mutant (negative control; blue curve) or (F) ABKAR-Kras (black curve) or bimABKAR-Kras (red curve) treated with 40 mM 2DG. ‘‘+ inhibitor’’ (green curve) in (B)
indicates Cos7 cells expressing bimABKAR that were pretreated for 1 hr with 20 mM compound C.
(C and G) Summary bar graphs comparing the average maximum responses of (C) ABKAR-NES and bimABKAR or (G) ABKAR-Kras and bimABKAR-Kras upon
2DG stimulation. Data shown represent mean ± SEM. ****p < 0.0001 according to unpaired Student’s t test.
(D and H) Representative pseudocolored images showing the responses of (D) ABKAR-NES and bimABKAR or (H) ABKAR-Kras and bimABKAR-Kras to 40 mM
2DG treatment in Cos7 cells. Warmer colors correspond to increasing FRET ratios. CFP and YFP images show the cellular distribution of probe fluorescence. The
arrowhead (inverted triangle) indicates the time at which drug was added during the imaging experiments. Scale bar represents 10 mm.
See also Figure S1.Experimental Procedures), we observed a dramatic emission ra-
tio increase of 61.8% ± 8.9% (n = 8), signifying a robust plasma
membrane AMPK response (Figures 4A and 4E). Conversely,
glucose deprivation alone resulted in a smaller ratio increase of
33.2%±4.2% (n= 44),which could then be increasedby an addi-
tional 30.6%± 4.0% (n = 19) uponH89 treatment (Figures 4B and
4E). These results indicate that basal PKA activity is able to
partially suppress the activation of plasma membrane AMPK.
Interestingly, stimulating PKA activity by treating the cells with
the adenylyl cyclase activator forskolin (Fsk) (Figure S2) led to a
gradual, 37.7% ± 5.6% (n = 5) increase in the bimABKAR-Kras
FRET response, which could then be increased by an additional
22.4% ± 3.6% (n = 5) following glucose deprivation (Figures 4C1474 Chemistry & Biology 22, 1470–1479, November 19, 2015 ª2015and 4E). Yet when AMPK activity was stimulated first via glucose
deprivation, the resulting bimABKAR-Kras response could not
be further enhanced by PKA stimulation. These results not only
confirm that PKA can both negatively and positively regulate
AMPK activity, but also reveal that this bidirectional regulation
can co-exist within the same cell.
PKA Stimulates Local AMPK Activity via LKB1
Phosphorylation
PKA is known to upregulate AMPK activity by phosphorylating
Ser431 of LKB1, an upstream kinase that is required for AMPK
to respond to metabolic stimuli such as glucose deprivation
(Shaw et al., 2004). In keeping with these effects, we foundElsevier Ltd All rights reserved
Figure 4. Bidirectional Regulation of AMPK Activity by PKA
(A–D) Representative single-cell traces of bimABKAR-Kras-expressing Cos7 cells treated with (A) 10 mMH89 followed by glucose deprivation (Glc), (B) glucose
deprivation followed by 10 mM H89, (C) 50 mM Fsk stimulation followed by glucose deprivation, or (D) glucose deprivation followed by 50 mM Fsk.
(E) Summary bar graph showing the overall responses of Cos7 cells transfected with bimABKAR-Kras and treated with 10 mM H89 (white), glucose deprivation
(Glc, black), or 50 mM Fsk (gray). Data shown represent mean ± SEM.
See also Figure S2.that LKB1 phosphorylation at Ser431 was significantly increased
within 5 min of Fsk treatment in Cos7 cells and blocked by H89
treatment (Figures 5A and 5B). Therefore, to further explore the
regulation of plasma membrane-localized AMPK activity by
PKA, we repeated the above experiments in HeLa cells, which
do not express LKB1 (Tiainen et al., 1999). In these cells, neither
PKA activation by Fsk nor glucose deprivation was capable of
eliciting a strong response from bimABKAR-Kras (Figures 5C
and 5D). Moreover, the AMPK response was rescued by heterol-
ogous overexpression of wild-type (WT) LKB1 but not the
kinase-dead LKB1-K78I mutant (LKB1 KD) (Shaw et al., 2004)
(Figures 5C and 5D). In LKB1 WT-expressing cells, Fsk stimula-
tion induced a 15.9% ± 1.7% (n = 14) FRET increase, followed by
an additional 19.0% ± 2.4% (n = 14) increase upon glucose
deprivation, whereas untransfected and LKB1 KD-expressing
cells exhibited only 3.2% ± 0.7% (n = 14) and 4.0% ± 1.4%
(n = 7) responses to Fsk and 7.5% ± 1.2% (n = 16) and 5.6% ±
0.8% (n = 12) responses to glucose deprivation (Figure 5D),
respectively. In addition, expressing the LKB1-S431A mutant
(LKB1 SA), which lacks the C-terminal PKA phosphorylation
site, largely abolished Fsk-stimulated AMPK activity (6.2% ±
1.1%, n = 11) in these cells while also somewhat diminishing
the response to glucose deprivation (12.1% ± 1.3%, n = 11) (Fig-
ures 5C and 5D). As a control, HeLa cells transfected with
AKAR4-Kras displayed a clear increase and decrease in FRET
following Fsk and H89 treatment, respectively, whereas glucose
deprivation had no effect (Figure S3). Interestingly, H89 treat-
ment led to similar increases in the bimABKAR-Kras response
regardless of LKB1 expression (Figures 5C and 5D), which
were abolished by pretreatment with the Ca2+ chelator BAPTA
(Figure S3). Like LKB1, CaMKII also serves as an upstream acti-
vating kinase for AMPK, and our results suggest the presence ofChemistry & Biology 22, 1470–147basal, CaMKK-mediated AMPK activity that remains under
direct negative regulation by PKA.
DISCUSSION
Despite their overall success in providing new insights into signal
transduction by visualizing real-time kinase signaling dynamics
in living cells, KARs often suffer from a constrained dynamic
range. Building upon the basic modular design of KARs, which
consists of an FRET pair and a kinase-inducible molecular
switch, we developed bimKARs to help overcome this limitation.
This study cements bimKARs as versatile tools to study kinase
signaling. First, we showed that bimKARs can be constructed
to successfully incorporate kinase docking domains, as evi-
denced by bimJNKAR. Using bimEKAR, we further demon-
strated that the inclusion of a lower-affinity PAABD does not
hinder the function of bimKARs.
One advantage of the bimKAR system over unimolecular
KARs is the potential for increased dynamic range, which allows
the visualization of small, yet physiologically relevant changes in
kinase signaling. For instance, the markedly enhanced dynamic
range of bimABKAR-Kras allowed us to visualize stimulated
AMPK activity near the plasma membrane. As stated above,
the enhanced range may be explained by the inherent physical
separation of the FP pair in the bimKAR system. While an
increased dynamic range is desired, it is not always observed,
as evidenced by bimEKAR and EKAR. However, this may be ex-
plained by the long, 72-Gly linker found in EKAR, which already
provides a considerable amount of separation between the two
halves of the molecular switch, mimicking a bimolecular system.
Other characteristics unique to the bimKAR system are less ad-
vantageous. For instance, the stoichiometry of the donor and the9, November 19, 2015 ª2015 Elsevier Ltd All rights reserved 1475
Figure 5. PKA Stimulates AMPK Activity via LKB1 Phosphorylation
(A) Representative western blot showing increased endogenous LKB1 phos-
phorylation (p-LKB1S431) relative to total LKB1 levels in Cos7 cells. 00, un-
treated; 50, 50 mM Fsk for 5 min; 450, 50 mM Fsk for 45 min; H89 + Fsk; 10 mM
H89 for 10 min followed by 50 mM Fsk for 45 min.
(B) Quantification of western blot data from (A). Data shown represent mean ±
SEM (n = 3). ***p < 0.001 versus untreated cells (00) according to one-way
ANOVA followed by Tukey’s multiple comparisons test.
(C) Representative single-cell traces showing the FRET ratio change in HeLa
cells expressing bimABKAR-Kras alone (LKB1, black curve) or co-trans-
fected with wild-type LKB1 (LKB1 WT, red curve), kinase-dead LKB1-K781
(LKB1 KD, blue curve), or non-phosphorylatable LKB1-S431A (LKB1 SA,
orange curve), and sequentially treated with 50 mM Fsk, glucose deprivation
(Glc), and 10 mM H89 at the indicated times.
(D) Bar graph summarizing the maximum individual responses to each treat-
ment shown in (C). Data shown represent mean ± SEM. *p < 0.05, **p < 0.01,
***p < 0.001, ****p < 0.0001 according to unpaired Student’s t test.
See also Figure S3.acceptor FPs is not fixed, a feature that is inherent to the unim-
olecular design. To ensure that signal analysis is performed
correctly, special care must be taken to balance the expression
levels of the two components of bimolecular reporters. Unequal
amounts of the two halves result in variable ratios that will both
compromise the sensitivity of the biosensors and make quantifi-1476 Chemistry & Biology 22, 1470–1479, November 19, 2015 ª2015cationmore complex (Zhang et al., 2002). Another concern when
using bimKARs is that they aremore likely to interact with endog-
enous molecules because the individual components of the mo-
lecular switch are expressed independently (Miyawaki, 2003;
Zhou et al., 2012). For instance, if the PAABD portion of the re-
porter were to bind endogenous substrates or have to compete
with endogenous PAABDs for the other half of the molecular
switch, the performance of the reporter and/or cellular signaling
machinery would be hindered. Nevertheless, this does not
appear to pose a problem for the current bimKARs, given their
robust responses. Moreover, as bimKARs are more sensitive to
diffusion constraints, there is the potential for them to display
reduced temporal sensitivity compared with their unimolecular
counterparts (Zhou et al., 2012).
In addition to testing the bimKAR design, we used these re-
porters to investigate plasma membrane AMPK activity. We
found that basal PKA activity is able to both suppress basal
and dampen stimulated AMPK activity. Phosphorylation of
AMPK by PKA prior to stimulation may provide an efficient
means to inhibit AMPK and, thus, tightly control its regulation.
Glucose-starvation-induced AMPK activity was previously
shown to be inhibited following 30min of PKA activation, as indi-
cated by the reduced phosphorylation of AMPK at the activation
site Thr172 (Djouder et al., 2010). Consistent with the ability of
PKA to inactivate AMPK, we found that inhibiting basal PKA ac-
tivity by treating cells with H89, either before or after acute
glucose deprivation, enhanced plasma membrane AMPK activ-
ity. However, increasing PKA activity appeared to have no effect
on glucose-starvation-induced AMPK activity (Figure 4D),
perhaps due to the different cell types used or differences in
whole-cell versus plasma membrane AMPK activity. On the
other hand, cAMP-elevating stimuli have also been shown to
enhance AMPK phosphorylation at Thr172 (Kimball et al., 2004;
Yin et al., 2003). Indeed, we found that stimulating PKA activity
in the presence of glucose actually induced AMPKactivity, which
was further increased by glucose deprivation.
The stimulatory effect of PKA toward AMPK is thought to be
mediated by the phosphorylation of LKB1 at Ser431, although
this remains controversial. For example, whereas some studies
have shown PKA to be necessary for LKB1 signaling and
AMPK activation (Kimball et al., 2004; Martin and St Johnston,
2003; Sapkota et al., 2001; Shelly et al., 2007), others indicate
that LKB1 activity is invariant (Lizcano et al., 2004). Notably, Fo-
garty and Hardie (2009) found that Ser431 was not required for
LKB1 to be fully active. Nevertheless, our results strongly impli-
cate PKA as a positive regulator of AMPK activity via LKB1; not
only did we observe the rapid induction of LKB1 Ser431 phos-
phorylation in Fsk-stimulated Cos7 cells, both LKB1 catalytic ac-
tivity and Ser431 were required to recapitulate PKA-induced
AMPK activity in HeLa cells. In fact, the LKB1-S431A mutant
was less capable of stimulating AMPK activity in response to
glucose deprivation than the WT protein (Figures 5C and 5D),
in agreement with a role for PKA in promoting LKB1 function
(Martin and St Johnston, 2003; Sapkota et al., 2001; Shelly
et al., 2007). Meanwhile, the inhibitory effect of basal PKA activity
persisted in the absence of LKB1 and appeared to correspond to
the direct inhibition of AMPK seen previously (Djouder et al.,
2010; Hurley et al., 2006). PKA has been observed to undergo
a switch from short-term AMPK inhibition to long-term AMPKElsevier Ltd All rights reserved
Figure 6. Model of AMPK Regulation by PKA
In resting (i.e., fed) cells, AMPK undergoes rapid basal phosphorylation at
Thr172 by activating kinases and weak basal phosphorylation by PKA at
inhibitory sites (here represented by Ser173). Whereas Thr172 is rapidly de-
phosphorylated by cellular phosphatase activity (PPase), inhibitory phos-
phorylation by PKA is only weakly antagonized, leading to the accumulation of
a stable pool of inactivated AMPK. At the same time, however, starvation or
PKA stimulation preferentially induces the phosphorylation of LKB1, leading to
the robust activation of naive AMPK via Thr172 phosphorylation.stimulation (Djouder et al., 2010); however, our results are the
first to demonstrate that these opposing regulatory mechanisms
can operate concurrently in the same cell. Specifically, our re-
sults are consistent with a model in which basally active PKA
weakly phosphorylates AMPK (represented here by Ser173),
creating a pool of inactivated AMPK. Meanwhile, stimulating
PKA leads to the preferential phosphorylation of LKB1, which
then rapidly and strongly activates naive AMPK via phosphoryla-
tion at Thr172 (Figure 6). Additional experiments are needed to
refine thismodel, especially to clarify the specific PKA phosphor-
ylation site(s) on AMPK.
Inconclusion,we report thatbimKARsareaversatile andadapt-
able set of tools for the study of real-time kinase signaling dy-
namics in live cells, capable of accommodating docking domains,
as well as various PAABDs, with the potential to offer enhanced
dynamic ranges versus unimolecular KARs. Furthermore, using
a plasma membrane-targeted bimKAR, we were able to visualize
AMPK activity for the first time at the plasma membrane and to
show that PKA activity can alternately serve as both a brake and
accelerator in the regulation of AMPK signaling.SIGNIFICANCE
Communication between and within cells enables our
bodies to maintain proper functioning. Elucidating the
mechanisms that underlie proper signaling benefits greatly
from the use of real-time approaches to monitor processes
whose dynamics can be lost with approaches that only offer
static glimpses. FRET-based biosensors allow for live-cell
imaging of kinase dynamics. FRET-based biosensors are
composed of two modules: a FRET pair and a kinase-induc-
ible molecular switch. We assessed the versatility and
adaptability of FRET-based bimKARs, which have proved
capable of functioning with additional or new domains. For
example, a kinase-specific docking domainwas added to in-Chemistry & Biology 22, 1470–147crease phosphorylation specificity and efficiency, and an
alternative PAABDwas added to demonstrate the generaliz-
able nature of the bimKARsystem. Finally, anAMPK-specific
bimKAR targeted to the plasma membrane revealed the
complex regulation of this kinase by PKA activity. Overall,
our studies highlight the many uses afforded by this system
and demonstrate how this class of biosensor will aid in our
understanding of signaling networks.
EXPERIMENTAL PROCEDURES
Detailed experimental procedures are provided in the Supplemental Experi-
mental Procedures.
Plasmid Construction
All plasmids were generated using standardmolecular biology techniques (see
Supplemental Experimental Procedures). Details of all biosensors used in this
work are summarized in Table S1.
Cell Culture and Transfection
HeLa cells were cultured in DMEM (Gibco) containing 1 g/l D-glucose and sup-
plemented with 10% fetal bovine serum (FBS; Sigma) and 1% penicillin-strep-
tomycin (pen/strep; Sigma-Aldrich). Cos7 cells were cultured in DMEM
containing 4.5 g/l D-glucose and supplemented with 10% FBS, 1% pen/strep,
and 1 mM NaPO4. Both cell lines were maintained at 37
C with 5% CO2. For
imaging, cells were plated onto sterile 35-mm glass-bottom dishes, trans-
fected with Lipofectamine2000 (Invitrogen) at 60%–70% confluency, and
grown for 24–48 hr.
Western Blotting
Cos7 cells were grown to 80% confluence in 6-cm dishes and treated with
50 mM Fsk with or without 10 mM H89 as indicated. Cells were then washed
with ice-cold Dulbecco’s PBS (DPBS; Gibco) and lysed in RIPA lysis buffer
containing protease inhibitor cocktail (Complete, EDTA-Free; Roche), 1 mM
PMSF, 1 mM Na3VO4, 1 mM NaF, and 25 nM calyculin A. Total cell lysates
were incubated on ice for 30 min and then centrifuged at 13,000 rpm for
30 min at 4C. Protein concentrations were determined using a BCA assay
kit (Pierce); 20 mg of protein from each sample was separated via 7.5%
SDS-PAGE and transferred to nitrocellulose. Membranes were blocked for
1 hr at room temperature in Tris-buffered saline containing 0.1% Tween 20
(TBST) and 5% BSA, and incubated overnight at 4C with primary antibodies
against p-LKB1-S431 (1:1000; EMD-Millipore) or human LKB1 (1:1000; Cell
Signaling) in TBST plus 5% BSA. After incubation with horseradish peroxi-
dase-conjugated goat-anti-rabbit secondary antibody (Pierce), the bands
were visualized using enhanced chemiluminescent detection (Pierce). Band in-
tensities were quantified using ImageJ software. p-LKB1 levels were first
normalized to total LKB1 expression in the same sample and then divided
by the untreated value to determine relative expression.
Imaging and Data Analysis
Cells were washed twice with Hank’s balanced salt solution (HBSS; Gibco)
supplemented with 20mMHEPES (pH 7.4) and 2.0 g/l D-glucose, then imaged
in the dark at 37C. Prior to imaging bimEKAR, cells were pre-incubated in
HBSS for 20 min at 37C. Cells were treated with drugs as indicated. For
glucose deprivation (Glc), cells were initially imaged in HBSS containing
4.5 g/l (25 mM) D-glucose. The glucose-containing medium was then washed
out and replaced with glucose-free HBSS. Images were acquired on an Zeiss
Axiovert 200Mmicroscope (Carl Zeiss) equippedwith a 403/1.3 NA oil-immer-
sion objective lens and a cooled charge-coupled device camera (Roper Scien-
tific) controlled by Metafluor 7.7 software (Molecular Devices). Dual-emission
ratio imaging was performed using a 420DF20 excitation filter, a 450DRLP
dichroic mirror, and two emission filters (475DF40 for CFP and 535DF25 for
YFP). Filter sets were alternated using a Lambda 10-2 filter changer (Sutter In-
struments). Exposure times were 50–500 ms, and images were acquired every
30–60 s. Background correction of the fluorescence images was performed by
subtracting the intensities of untransfected cells or regions of the imaging dish9, November 19, 2015 ª2015 Elsevier Ltd All rights reserved 1477
with no cells. Time courses were normalized by setting the emission ratio
before drug addition to 1. Graphs were plotted using GraphPad Prism version
5.0f (GraphPad Software), and statistical analyses were performed using the
same software. Statistical significance was set at p < 0.05.
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Supplemental Information includes Supplemental Experimental Procedures,
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